(1)
Jonušaitė, I.; Giedraitienė, N.; Kaubrys, G.; Kizlaitienė, R. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of Ofatumumab. NS 2024, 27 (Nr. 3 (97), 127-135. https://doi.org/10.29014/NS.2023.27.97.1.